Similar articles for PMID: 16696191

Year	Number of Results
1987	1
1993	1
1995	1
1996	3
1998	1
1999	1
2000	1
2001	2
2002	3
2003	6
2004	2
2005	6
2006	3
2007	5
2008	7
2009	9
2010	8
2011	8
2012	9
2013	7
2014	2
2015	3
2016	2
2017	1
2018	2
2020	2
2022	0

1

An alternative paclitaxel self-emulsifying microemulsion formulation: preparation, pharmacokinetic profile, and hypersensitivity evaluation.

Zhang XN, Tang LH, Gong JH, Yan XY, Zhang Q. Zhang XN, et al. PDA J Pharm Sci Technol. 2006 Mar-Apr;60(2):89-94. PDA J Pharm Sci Technol. 2006. PMID: 16696191

2

An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile.

He L, Wang GL, Zhang Q. He L, et al. Int J Pharm. 2003 Jan 2;250(1):45-50. doi: 10.1016/s0378-5173(02)00478-7. Int J Pharm. 2003. PMID: 12480272

3

[Studies on hypersensitivity and pharmacokinetics of paclitaxel microemulsion].

He L, Wang GL, Zhang Q. He L, et al. Yao Xue Xue Bao. 2003 Mar;38(3):227-30. Yao Xue Xue Bao. 2003. PMID: 12830723 Chinese.

4

Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.

Park JH, Park JH, Hur HJ, Woo JS, Lee HJ. Park JH, et al. Eur J Pharm Sci. 2012 Feb 14;45(3):296-301. doi: 10.1016/j.ejps.2011.11.021. Epub 2011 Dec 8. Eur J Pharm Sci. 2012. PMID: 22172604

5

Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.

Nornoo AO, Osborne DW, Chow DS. Nornoo AO, et al. Int J Pharm. 2008 Feb 12;349(1-2):108-16. doi: 10.1016/j.ijpharm.2007.07.042. Epub 2007 Aug 7. Int J Pharm. 2008. PMID: 17869459

6

Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics.

Nornoo AO, Chow DS. Nornoo AO, et al. Int J Pharm. 2008 Feb 12;349(1-2):117-23. doi: 10.1016/j.ijpharm.2007.07.043. Epub 2007 Aug 7. Int J Pharm. 2008. PMID: 17869458

7

Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.

Nornoo AO, Zheng H, Lopes LB, Johnson-Restrepo B, Kannan K, Reed R. Nornoo AO, et al. Eur J Pharm Biopharm. 2009 Feb;71(2):310-7. doi: 10.1016/j.ejpb.2008.08.015. Epub 2008 Aug 29. Eur J Pharm Biopharm. 2009. PMID: 18793723

8

Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel.

Constantinides PP, Lambert KJ, Tustian AK, Schneider B, Lalji S, Ma W, Wentzel B, Kessler D, Worah D, Quay SC. Constantinides PP, et al. Pharm Res. 2000 Feb;17(2):175-82. doi: 10.1023/a:1007565230130. Pharm Res. 2000. PMID: 10751032

9

Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization.

Li Y, Zhao X, Zu Y, Zhang Y. Li Y, et al. Int J Pharm. 2015 Jul 25;490(1-2):324-33. doi: 10.1016/j.ijpharm.2015.05.070. Epub 2015 May 28. Int J Pharm. 2015. PMID: 26027492

10

Intravenous administration of paclitaxel in Sprague-Dawley rats: what is a safe dose?

Shord SS, Camp JR. Shord SS, et al. Biopharm Drug Dispos. 2006 May;27(4):191-6. doi: 10.1002/bdd.503. Biopharm Drug Dispos. 2006. PMID: 16566060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed